BENEFIT-OL / Estudio abierto de extensión a largo plazo en pacientes con hipertensión pulmonar tromboembólica crónica (HPTC) inoperable que hayan completado el protocolo AC-052-366/BENEFIT - BENEFIT-O
- Conditions
- Pacientes con hipertensión pulmonar tromboembólica crónica inoperable (HPTC)
- Registration Number
- EUCTR2005-002900-40-ES
- Lead Sponsor
- Actelion Pharmaceuticals Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 128
·Pacientes que hayan completado el período de tratamiento de 16 semanas del protocolo AC-052-366/BENEFIT
·Firma del consentimiento informado antes de iniciar ningún procedimiento dictado por el estudio
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
·Cualquier violación grave del protocolo AC-052-366/BENEFIT
·Embarazo o lactancia
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.